u/Embarrassed_Cup_1112

75% growth in ONE month… are GLP-1s about to go mainstream in India?

Just saw a report saying semaglutide generic launches pushed GLP-1 drug sales up by 75% in a single month. That’s honestly insane growth for such a short period.

What’s interesting is that it seems generics are expanding access instead of hurting demand for branded versions. Feels like we might be entering the phase where GLP-1s stop being a niche “rich people” thing and become way more common.

I’m curious how this changes things over the next few years:

• More people finally getting treatment?
• Less stigma around obesity medication?
• Doctors prescribing them more aggressively?
• Or are we heading toward overuse and another healthcare trend cycle?

Feels like this could genuinely reshape the obesity + diabetes treatment market in India